Primary |
Ill-defined Disorder |
36.4% |
Drug Use For Unknown Indication |
22.7% |
Vasculitis |
9.1% |
Asthma |
4.5% |
Biliary Cirrhosis |
4.5% |
Colitis Ulcerative |
4.5% |
Leukocytoclastic Vasculitis |
4.5% |
Myalgia |
4.5% |
Rheumatoid Arthritis |
4.5% |
Whiplash Injury |
4.5% |
|
Vision Blurred |
15.0% |
Blood Urea Increased |
10.0% |
Pneumonia |
10.0% |
Surgery |
10.0% |
Hypotension |
5.0% |
Ileostomy |
5.0% |
Nausea |
5.0% |
Pain |
5.0% |
Skin Odour Abnormal |
5.0% |
Stomach Discomfort |
5.0% |
Swelling Face |
5.0% |
Therapeutic Response Delayed |
5.0% |
Thyroxine Decreased |
5.0% |
Transplant Failure |
5.0% |
Urinary Bladder Atrophy |
5.0% |
|
Secondary |
Renal Transplant |
50.0% |
Rheumatoid Arthritis |
23.7% |
Immunosuppression |
18.4% |
Prostate Cancer Metastatic |
5.3% |
Asthma |
2.6% |
|
Hepatitis C |
21.4% |
Pneumonia |
14.3% |
B-cell Lymphoma |
7.1% |
Exposure During Pregnancy |
7.1% |
Hepatic Fibrosis |
7.1% |
Kidney Transplant Rejection |
7.1% |
Pain |
7.1% |
Pyelonephritis |
7.1% |
Sepsis |
7.1% |
Swelling Face |
7.1% |
Transplant Rejection |
7.1% |
|
Concomitant |
Product Used For Unknown Indication |
36.6% |
Rheumatoid Arthritis |
15.0% |
Drug Use For Unknown Indication |
14.6% |
Osteoporosis |
4.2% |
Crohn's Disease |
4.0% |
Asthma |
3.8% |
Juvenile Arthritis |
2.4% |
Premedication |
2.4% |
Ill-defined Disorder |
2.1% |
Immunosuppression |
2.1% |
Pain |
1.9% |
Renal Transplant |
1.9% |
Myositis |
1.6% |
Hypertension |
1.3% |
Hypopituitarism |
1.3% |
Psoriatic Arthropathy |
1.3% |
Diabetes Mellitus |
1.0% |
Prophylaxis Against Transplant Rejection |
1.0% |
Lower Respiratory Tract Infection |
0.8% |
Multiple Sclerosis |
0.8% |
|
Liver Function Test Abnormal |
7.9% |
Psychotic Disorder |
7.9% |
Urinary Tract Infection |
7.9% |
Vomiting |
7.9% |
Colitis Ulcerative |
5.3% |
Malaise |
5.3% |
Rash |
5.3% |
Rectal Perforation |
5.3% |
Allergic Granulomatous Angiitis |
3.9% |
Asthma |
3.9% |
Autoimmune Pancreatitis |
3.9% |
Chest Discomfort |
3.9% |
Death |
3.9% |
Headache |
3.9% |
Infusion Related Reaction |
3.9% |
Lung Infection |
3.9% |
Progressive Multifocal Leukoencephalopathy |
3.9% |
Renal Failure |
3.9% |
Tooth Abscess |
3.9% |
Upper Respiratory Tract Infection |
3.9% |
|